Abiopharma

Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network

FORM 6-K- Company Presentation

VitalHub Announces Deployments of Referral Management Solutions

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

SD Government announces Federal Aviation Administration STC approval for Gogo Galileo HDX installation on the Pilatus PC-12

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)